Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 19, 2001

View Archived Issues

Study suggests topiramate may be useful in nicotine addiction

3M and GSK collaborate to formulate novel respiratory drugs

Interim results show OrCel's efficacy and speed in healing diabetic ulcers

NPS Pharmaceuticals continues progress during Q3 2001

New clinical studies support effectiveness of Eros Therapy in female sexual dysfunction

Blockade of mglu5 receptors reduces L-DOPA-induced dyskinesia

New HDL-elevating agent characterized by AtheroGenics at American Heart Association meeting

Antisense approach to preventing intimal hyperplasia post-PTCA examined in pig model

Survival of transplanted dopamine neurons significantly increased using CEP-1347

Fiscal Q2 at AnorMED marked by progress in clinical development programs

Catalytic antioxidant AEOL-10150 protects mice from ischemic brain damage

Peptide memory enhancer progresses through preclinical development

Orally active p38 MAP kinase effectively inhibits progression of collagen-induced arthritis

Phase II clinical results for 5G1.1 anticomplement antibody support further testing in RA

DPC-333, a selective, orally active TACE inhibitor with potential in inflammation

Uriach describes potent and selective COX-2 inhibitors

Novel 5-HT2C receptor antagonists and uses of these compounds patented by Fujisawa

Taisho discloses new series for renal and cerebrovascular disorders

Pyridyl-thiazolyl compounds for PDE4-mediated conditions

Orally available triterpenes for liver diseases

Merck receives patent coverage for new GnRH antagonists

FR-900482 analogues with antitumor activity under study in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Sumitomo’s DSP-3456 exerts antidepressant-like effects
BioWorld Science
About one-third of patients with major depressive disorder (MDD) are treatment resistant. Ketamine is very effective in treatment-resistant depression, but it is...